Name: UMIN ID:
Unique ID issued by UMIN | C000000058 |
---|---|
Receipt number | R000000102 |
Scientific Title | A Multicenter Randomized Controlled Trial Designed to Evaluate Follow-up Surveillance Strategies for Colorectal Cancer: The Japan Polyp Study |
Date of disclosure of the study information | 2005/08/12 |
Last modified on | 2021/08/24 17:50:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/08/12 15:28:15 | ||
2 | Update | 2005/08/12 15:29:40 | Date of disclosure of the study information |
|
3 | Update | 2005/08/12 15:32:11 | Institute Institute |
|
4 | Update | 2005/08/12 15:33:13 | Condition |
|
5 | Update | 2005/08/12 16:25:06 | Trial characteristics_1 Developmental phase |
|
6 | Update | 2005/08/12 16:31:37 | Randomization unit Control Stratification Dynamic allocation Institution consideration Concealment |
|
7 | Update | 2005/08/12 18:52:21 | ||
8 | Update | 2008/01/06 12:50:33 | Recruitment status Last follow-up date |
|
9 | Update | 2008/01/07 12:19:50 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address TEL Last name of contact person Last name of contact person Organization Organization Division name Division name Address Organization Institute Institute Organization |
|
10 | Update | 2008/01/08 11:42:48 | UMIN ID1 |
|
11 | Update | 2008/01/08 11:44:44 | Date analysis concluded |
|
12 | Update | 2008/01/08 11:46:35 | Name of person sending information Organization1 |
|
13 | Update | 2008/02/12 10:17:41 | Organization1 Email1 |
|
14 | Update | 2008/11/24 22:10:20 | Last name of contact person Last name of contact person Address TEL |
|
15 | Update | 2011/06/07 17:15:19 | Organization Division name Organization Division name Name of person sending information Organization Division name Address |
|
16 | Update | 2012/02/28 11:00:30 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
17 | Update | 2012/02/28 11:02:53 | Last follow-up date Date analysis concluded |
|
18 | Update | 2012/02/28 11:09:54 | Key secondary outcomes Key secondary outcomes |
|
19 | Update | 2012/11/07 08:38:30 | Last follow-up date Date analysis concluded |
|
20 | Update | 2013/10/08 13:15:59 | Division name Division name Address TEL Name of person sending information Name of person sending information |
|
21 | Update | 2014/03/26 10:10:47 | Publication of results |
|
22 | Update | 2016/06/21 21:19:10 | Name of person sending information Name of person sending information Name of primary person or sponsor Organization Category of Funding Organization |
|
23 | Update | 2019/06/27 09:41:45 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
24 | Update | 2019/12/22 10:02:53 | Date of IRB |
|
25 | Update | 2019/12/22 10:03:40 | Number of participants that the trial has enrolled |
|
26 | Update | 2020/04/15 17:23:06 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
27 | Update | 2020/04/15 17:40:45 | Division name Division name Division name Division name Address Address Institute Institute |
|
28 | Update | 2020/04/15 17:44:48 | Last follow-up date Date analysis concluded |
|
29 | Update | 2020/06/12 15:53:50 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
30 | Update | 2021/08/24 17:49:39 | URL related to results and publications Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD |
|
31 | Update | 2021/08/24 17:49:58 | Recruitment status |
|
32 | Update | 2021/08/24 17:50:50 | Publication of results |